The teratocarcinoma cell line NTERA2 is recently used in a wide range of researches (from developmental biology to toxicology, for their ability to be induced to neural differentiation. In order to study the genetic potential of these cells, it is needed to use methods for gene silencing and/or mRNA interference, allowing cell viability and further differentiation. To check these features, we simultaneously tested the transfection efficiency of NTERA2, A549 and HeLa cells with Metafectene PRO (Biontex, Germany) and another optimal transfection reagent currently used in our Laboratory, using as a reporter gene the DsRed2 vector (Clontech, Mountain View, CA). Under our culture conditions for NTERA2 and HeLa cells, Metafectene PRO transfection method was found to possess high throughput performance, that allows low concentration rate and low exposure time to excitation light source, thus reducing both toxicity and phototoxicity.
T he teratocarcinoma cell line NTERA2 is a human embryonic cell line, used in a wide range of researches (from developmental biology to toxicology), for their ability to be induced to pluripotent differentiation.
In order to study the potential of these cells, gene modification is needed to check the effects of silencing or expressing genes, without compromising viability or further differentiation.
Cell transfection is used in biomedical and biological research to study the role of individual gene products in vitro or in vivo. Viral and non-viral gene transfer systems are available from several suppliers, and several cell lines and primary cells can efficiently be transfected (Zhang et al., 2001; Banerjee et al., 2001) .
For NTERA2 cells, the method mainly used to get transfection is up-to-date infection by viral vectors.
In this work, we examined the efficacy of a novel transfect ion reagent Metafectene (Biontex, Germany) using DsRed2 vector (Clontech, Mountain View, CA) in human NTERA2 cells as compared to other cell lines, such as HeLa cells and A549 cells.
Comparison among the different cell lines was carried out because, while HeLa and A549 cells are rather stable, cultured NTERA2 cells are difficult to transfect, being very sensitive to culture conditions. Actually, the pluripotent NTERA2 cell lines are used to check differentiation, and a high degree of survival is needed.
We established the concentrations of Metafectene causing efficiency of transfection without signs of cell degeneration that are frequently observed when using calcium phosphate or electroporation.
The efficiency/toxicity balance was compared with a non-liposomal multicomponent transfection medium, previously routinely used in our Laboratory.
This work is carried out in the context of a research aimed at using NTERA2 cells as a material for the study of neural differentiation.
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Materials and Methods
Cell lines
The human cervical cancer cell line HeLa and the human teratocarcinoma cell line NTERA2-D1 were obtained from the American Type Culture Collection (ATCC) (Rockville, MD) and maintained in an atmosphere of 5% CO2, at 37°C in Dulbecco's modified Eagle's MEM (DMEM) supplemented with 10% FCS (Celbio, Italy), 1 mM L-glutamine and antibiotics (100 units/mL penicillin and 100 µg/mL streptomycin).
The human lung carcinoma cell line A549 were obtained from the ATCC (Rockville, MD) and maintained in an atmosphere of 5% CO2, at 37°C in RPMI-1640 supplemented with 10% FCS (Celbio, Italy), 1 mM L-glutamine and antibiotics (penicillin and streptomycin).
Transfection protocol
For transiently transfection with a red fluorescent protein, HeLa (1×10 5 cells/well), NTERA2 (1×10 5 cells/well) and A549 (4×10 4 cells/well) cell lines were seeded on poly-L-lysine coated slides (Sigma Chem Co., Saint Louis, MO) in 1 mL of medium in 12-well culture plates, resulting in about 80-90% confluency within 24 hours. Cells were transfected one day later with DsRed2 vector (Clontech, Mountain View, CA) using Metafectene PRO (Biontex, Germany) and a transfection reagent routinely (TRR) used in our laboratory according to the manufacturer's instructions.
Cells were pre-washed with PBS and then covered with 1 mL of serum-free medium. Metafectene PRO was complexed with the expression construct. The metafectene solution and construct (DNA) solution was prepared separately mixing Metafectene PRO/DNA with 50 µL serum free medium (ratio Metafectene PRO/DNA 2:1, 4:1, 6:1), and after that the two solution were mixed. The mixture was incubated for 15 min at room temperature and then added in a volume of 0.1 mL per well.The cells were incubated in serum-free DMEM or RPMI 1640 and after 24 h of transfection were fixed with 4% paraformaldehyde (pH 7.4) for 10 min, and then stained with Hoechst 33258 (5 mg/L) for 10 min at room temperature and washed twice in distilled water.The coverslips were removed and mounted on glass microscope slides with SuperMount ® (BioGenex, San Ramon, CA) to achieve optimal fluorescence. RFP-cells (red fluorescent positive cells) were analyzed using an Olympus IX71 microscope (Olympus Italia s.r.l., Italy). Images were acquired at the excitation wave length of 540 nm and processed using the analySIS software package (Soft Imaging System GmbH, Germany). Cell morphology was evaluated by inverted phase contrast microscopy at 10-20x magnification.
Cytotoxicity assay
To determine cell lines viability, a MTT assay Co., MO]) treatment, the cells were exposed for 24 hours to the Metafectene PRO and transfection reagent routinely used in our laboratory formulations at the same end concentrations used for the transfection experiments.
The MTT assay was performed according to the manufacturer's instructions. The remaining viable cells with MTT dye uptake were determined by measuring the optical density at 520 nm in a spectrophotometer (6405 Ultra Violet/Visible, Barloworld Scientific Ltd, United Kingdom).
Results
Transfection efficiency
In HeLa Cells, the transfection efficiency was very high: at concentration 2:1 the ratio of transfected cells vs non transfected cells was approximately 30-35% both with TRR used and Metafectene PRO (Figure 1 ): DsRed2 vector displays a consistent and homogeneous distribution when transfected in HeLa cells.
In contrast, transfection of lung carcinoma cell line A549 provided no mentionable RFP-positive cells, either with Metafectene PRO or with the current transfection method (not shown).
In NTERA2 cells (Figure 2) , the transfection efficiency of Metafectene PRO was similar to that obtained in HeLa cells. We measured the transfection efficiency by comparing the exposure times needed to acquire the images by use of the analySIS software: Metafectene PRO transfected cells were acquired with an exposure time lower (500 ms at 20X magnification) than of TRR transfected cells (1 s at 20X magnification) ( Figure 3A ). This also allows to decrease possible phototoxicity when experiments on living cells are needed.
Cytotoxicity
In HeLa cells, Metafectene PRO and TRR revealed no toxicity in either concentration used, as determined microscopically (Figure 1 B,D,F,H) and by MTT assay ( Figure 3B ).
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Letter to the editor NTERA2 seem to be more susceptible to the toxic effect of Metafectene PRO (4:1 and 6:1) as compared to HeLa cells. Nevertheless, the fact that Metafectene PRO allows a good transfection also at lower concentrations (2:1) allows to obtain a good transfection with low toxicity.
Discussion
An optimized protocol for mammalian adherent cells transfection was developed, based on polycationic liposomal transfection reagent, Metafectene PRO. Using the DsRed2 vector and Metafectene PRO Transfection Reagent resulted in efficient transfection of the teratocarcinoma cell line NTERA2 and cervical cancer cell line HeLA with the optimum around Metafectene PRO/DNA ratio of 2:1 after 24 hour incubation. As for all the transfection methods, there is a clear inverse relationship between transfection efficiency and toxicity; anyway, thank to the high transfection performance, Metafectene PRO seems a very good reagent to detect expressed fluorescent protein with low concentration and low exposure time. The transfected NTERA2 cells retained their viability and proliferation ability at the same rate as the HeLa. Thus, both chemical and phototoxicity may be reduced and this allows a very good throughput of the transfection. The ability NTERA2 cells, as a good surrogate of stem cells, to differentiate into specific cell types holds a potential for studying the basis of stem cell therapeutic use in cell and gene therapy. Realization of this potential depends on efficient and optimized protocols for genetic manipulation of cultured cells. 
